These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9398910)

  • 1. Susceptibility of Helicobacter pylori to the bactericidal activity of human serum.
    Gonzalez-Valencia G; Perez-Perez GI; Washburn RG; Blaser MJ
    Helicobacter; 1996 Mar; 1(1):28-33. PubMed ID: 9398910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of Campylobacter isolates to the bactericidal activity of human serum.
    Blaser MJ; Smith PF; Kohler PF
    J Infect Dis; 1985 Feb; 151(2):227-35. PubMed ID: 3968449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
    Densen P; McRill CM; Ross SC
    J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of Campylobacter jejuni to strain-specific bactericidal activity in sera of infected patients.
    Pennie RA; Pearson RD; Barrett LJ; Lior H; Guerrant RL
    Infect Immun; 1986 Jun; 52(3):702-6. PubMed ID: 3710581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of immunoglobulin G in killing of Borrelia burgdorferi by the classical complement pathway.
    Kochi SK; Johnson RC
    Infect Immun; 1988 Feb; 56(2):314-21. PubMed ID: 3276623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation.
    Jarvis GA; Vedros NA
    Infect Immun; 1987 Jan; 55(1):174-80. PubMed ID: 3098684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-dependent alternative pathway killing of Haemophilus influenzae type b.
    Steele NP; Munson RS; Granoff DM; Cummins JE; Levine RP
    Infect Immun; 1984 May; 44(2):452-8. PubMed ID: 6609128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of Campylobacter fetus infections. Failure of encapsulated Campylobacter fetus to bind C3b explains serum and phagocytosis resistance.
    Blaser MJ; Smith PF; Repine JE; Joiner KA
    J Clin Invest; 1988 May; 81(5):1434-44. PubMed ID: 3366901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the susceptibility of Pseudomonas aeruginosa to complement-mediated killing: role of antibodies to the rough lipopolysaccharide on serum-sensitive strains.
    Schiller NL
    Infect Immun; 1988 Mar; 56(3):632-9. PubMed ID: 3125110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of the role of antibodies against Helicobacter pylori in inhibiting adherence of the organism to gastric cells.
    Clyne M; Thomas J; Weaver L; Drumm B
    Gut; 1997 Jun; 40(6):731-8. PubMed ID: 9245926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement activation directly induced by Helicobacter pylori.
    Berstad AE; Høgåsen K; Bukholm G; Moran AP; Brandtzaeg P
    Gastroenterology; 2001 Apr; 120(5):1108-16. PubMed ID: 11266375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bactericidal effect of bovine normal and immune serum, colostrum and milk against Helicobacter pylori.
    Korhonen H; Syväoja EL; Ahola-Luttila H; Sivelä S; Kopola S; Husu J; Kosunen TU
    J Appl Bacteriol; 1995 Jun; 78(6):655-62. PubMed ID: 7615421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.
    Baker CJ; Edwards MS; Webb BJ; Kasper DL
    J Clin Invest; 1982 Feb; 69(2):394-404. PubMed ID: 7035495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum bactericidal activity against Helicobacter pylori in patients with hypogammaglobulinaemia.
    Desar IM; van Deuren M; Sprong T; Jansen JB; Namavar F; Vandenbroucke-Grauls CM; van der Meer JW
    Clin Exp Immunol; 2009 Jun; 156(3):434-9. PubMed ID: 19438595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies directed against gonococcal protein I vary in bactericidal activity.
    Joiner KA; Warren KA; Tam M; Frank MM
    J Immunol; 1985 May; 134(5):3411-9. PubMed ID: 3920319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of heparin binding on Helicobacter pylori resistance to serum.
    Dubreuil JD; Ruggiero P; Rappuoli R; Del Giudice G
    J Med Microbiol; 2004 Jan; 53(Pt 1):9-12. PubMed ID: 14663099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
    Tesh VL; Duncan RL; Morrison DC
    J Immunol; 1986 Aug; 137(4):1329-35. PubMed ID: 3525676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.